Leidos (NYSE:LDOS - Get Free Report) announced its quarterly earnings data on Tuesday. The aerospace company reported $2.97 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.47 by $0.50, Zacks reports. Leidos had a return on equity of 30.93% and a net margin of 7.53%. Leidos updated its FY 2025 guidance to 10.350-10.750 EPS.
Leidos Price Performance
LDOS stock opened at $147.87 on Tuesday. The company has a market capitalization of $18.96 billion, a PE ratio of 16.00, a price-to-earnings-growth ratio of 1.65 and a beta of 0.66. The company's fifty day moving average price is $138.18 and its 200-day moving average price is $149.56. Leidos has a one year low of $123.62 and a one year high of $202.90. The company has a debt-to-equity ratio of 0.91, a quick ratio of 1.13 and a current ratio of 1.21.
Leidos Dividend Announcement
The business also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Stockholders of record on Monday, June 16th will be given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 1.08%. The ex-dividend date of this dividend is Monday, June 16th. Leidos's payout ratio is currently 17.32%.
Wall Street Analyst Weigh In
Several equities analysts have recently issued reports on LDOS shares. William Blair lowered Leidos from an "outperform" rating to a "market perform" rating in a research report on Friday, February 21st. StockNews.com cut shares of Leidos from a "strong-buy" rating to a "buy" rating in a report on Wednesday, April 30th. Wells Fargo & Company cut their price target on shares of Leidos from $191.00 to $173.00 and set an "overweight" rating on the stock in a report on Tuesday, April 8th. TD Cowen lowered shares of Leidos from a "buy" rating to a "hold" rating and decreased their price objective for the stock from $200.00 to $165.00 in a report on Wednesday, January 8th. Finally, Truist Financial cut their target price on Leidos from $165.00 to $155.00 and set a "buy" rating on the stock in a research note on Monday, April 14th. Five analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $179.23.
Get Our Latest Research Report on Leidos
Insider Buying and Selling at Leidos
In related news, Director Robert C. Kovarik, Jr. sold 1,511 shares of the business's stock in a transaction on Thursday, February 13th. The shares were sold at an average price of $134.56, for a total value of $203,320.16. Following the sale, the director now owns 6,408 shares in the company, valued at approximately $862,260.48. The trade was a 19.08 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Gary Stephen May sold 2,128 shares of the stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $131.24, for a total transaction of $279,278.72. Following the transaction, the director now owns 11,264 shares of the company's stock, valued at $1,478,287.36. This trade represents a 15.89 % decrease in their position. The disclosure for this sale can be found here. 0.96% of the stock is currently owned by insiders.
Leidos Company Profile
(
Get Free Report)
Leidos Holdings, Inc, together with its subsidiaries, provides services and solutions in the defense, intelligence, civil, and health markets in the United States and internationally. The company operates through Defense Solutions, Civil, and Health segments. The Defense Solutions segment offers national security solutions and systems for air, land, sea, space, and cyberspace for the U.S.
Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Leidos, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Leidos wasn't on the list.
While Leidos currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.